Labcorp Holdings Inc.
LHLast close · Oct 16, 2026317.95−7.12 (−2.19%)
Market cap$25.8B
7 firms' latest targets, last 90 days: median $352.00 ($306.00–$380.00), 11% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-09-21 | Truist | $365.00 | — | +15% |
| 2026-09-11 | UBS | $380.00 | ▲ 19% | +20% |
| 2026-09-11 | Barclays | $330.00 | ▲ 3% | +4% |
| 2026-08-10 | Mizuho Securities | $355.00 | ▲ 11% | +12% |
| 2026-07-31 | Morgan Stanley | $338.00 | — | +6% |
| 2026-07-31 | Deutsche Bank | $306.00 | — | -4% |
| 2026-07-31 | Baird | $352.00 | ▲ 5% | +11% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $12.2B | +3% | $4.77 | -66% | est. $12.1B+0% | est. $13.54 | 9 |
| 2024reported | $13.0B | +7% | $8.84 | +85% | est. $13.0B+0% | est. $14.52 | 12 |
| 2025reported | $14.0B | +7% | $10.46 | +18% | est. $14.0B+0% | est. $16.33 | 13 |
| 2026 | $14.8B | +6% | $18.35 | +12% | $14.7B–$14.8B | $18.13–$18.46 | 8 |
| 2027 | $15.5B | +5% | $19.83 | +8% | $15.3B–$15.7B | $18.87–$20.26 | 13 |
| 2028 | $16.2B | +5% | $21.60 | +9% | $16.2B–$16.3B | $19.42–$24.45 | 12 |
| 2029 | $17.2B | +6% | $23.83 | +10% | $17.1B–$17.4B | $23.60–$24.11 | 10 |
| 2030 | $15.2B | -11% | $25.57 | +7% | $15.1B–$15.4B | $25.33–$25.88 | 6 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.